Your browser doesn't support javascript.
loading
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study.
Kian, Waleed; Zemel, Melanie; Kestenbaum, Emily H; Rouvinov, Keren; Alguayn, Wafeek; Levitas, Dina; Ievko, Anna; Michlin, Regina; Abod, Moataz A; Massalha, Ismaell; Chernomordikov, Elena; Sharb, Adam A; Shalata, Walid; Levison, Esther; Roisman, Laila C; Lavrenkov, Konstantin; Peled, Nir; Nesher, Lior; Yakobson, Alexander.
Afiliação
  • Kian W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Zemel M; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Kestenbaum EH; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Rouvinov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Alguayn W; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Levitas D; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Ievko A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Michlin R; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Abod MA; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Massalha I; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Chernomordikov E; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Sharb AA; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Shalata W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Levison E; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Roisman LC; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Lavrenkov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
  • Peled N; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Nesher L; Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel.
  • Yakobson A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.
Medicine (Baltimore) ; 101(2): e28561, 2022 Jan 14.
Article em En | MEDLINE | ID: mdl-35029223
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Vacinas contra COVID-19 / COVID-19 / Vacina BNT162 / Neoplasias Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Vacinas contra COVID-19 / COVID-19 / Vacina BNT162 / Neoplasias Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article